Introduction
Cardiac Sarcoma is a very rare kind of tumor. Primary Cardiac Sarcomas are malignant tumors which originate in the heart [1] . They have an incidence of 0.0017 to 0.0190 %. Among all cardiac tumors 75% are myxomas (benign) whereas 25% are malignant cardiac tumors [2] . Among the malignant cardiac tumors, 75% are cardiac sarcomas. The right side of the heart is usually affected by these rare malignant tumors. Hemangiosarcoma is the most common type of sarcoma usually affecting the right atrium. The timely diagnosis of Primary Cardiac Sarcomas is usually overlooked because of their rare occurrence and the non-specific signs and symptoms. The most usual symptoms of Cardiac Sarcomas are chest pain, fatigue, dyspnea, infarction of limbs (usually due to embolisms from the left side of the heart), stroke and metastasis to different parts of the body. Tumors with deep infiltration can cause Superior Vena Cava Syndrome and Dysphonia because of recurrent laryngeal nerve palsy [3] . Signs including hypotension, malaise, tachycardia, diminished heart sounds and a friction rub may be present. Intractable cardiac failure can result from cardiac tamponade. If the myocardium gets involved it can result in arrhythmias, angina, heart block, heart failure, infarction, valvular obstruction or valvular insufficiency. Primary Cardiac Sarcomas include Rhabdomyosarcoma, pericardial effusion. There was no conclusive evidence of tamponade physiology based on echocardiographic findings. There appeared to be a loculated exudate attached to the right ventricular surface. The free wall of the rightatrium appeared to have diastolic indentation. (Figure 1 A-C). This revealed a large infiltrative mass measuring about 9.1 cm craniocaudually, 6.5 cm transversely, and 6 cm in anteroposterior diameter. Enhancement was demonstrated. The mass involved the posterolateralwall of the left atrium and a portion of the left ventricle. The mass extended superiorly and partially surrounded the pulmonary veins on the left. There were several nodular components of the mass that were protruding into the lumen of the left atrium. There was involvement of the mitral valve.
Based on this data, our differentials included cardiac sarcoma as well as metastatic sarcoma or melanoma, and lymphoma.
Cytology returned for reactive mesothelial cells. Cardiac biopsy was pursued to illicit pathology. This returned for primary cardiac sarcoma. The patient was transferred to Cleveland Clinic, Ohio for further management including oncology evaluation.
Case 2
A 62 year old male presented for evaluation of one month history of progressive cold, headache, and general malaise. This was complicated with recent development of new shortness of breath. Further history revealed left shoulder pain. He asked to be treated for his ongoing "Flu". He had undergone numerous treatments under his primary care's guidance including antibiotics. Vital signs were for a blood pressure of 88/72 mm Hg and heart rate of 93 beats per minute. Cardiopulmonary exam revealed distant heart sounds. Chest radiograph revealed an enlarged cardiac silhouette. EKG revealed low voltage QRS. An echocardiogram done in the emergency room revealed a large pericardial effusion tamponade physiology.
Cardiology team and Cardiothoracic surgery teams were in agreement that emergent pericardiocentesis be performed. This returned 900 cc of sanguinous fluid. The fluid was sent for cell count and differential, LDH, protein, gram stain and cultures (viral, fungal and AFB). These studies returned normal. A pericardial drain was established. A trans-esophageal echocardiogram ( Figure 2) showed a 3.8 x 3.5cm right atrial mass with mobile components. There appeared to be transmural extension. Based on site of origin andtransmural extension, initial differentials included metastasis or sarcomatous malignant primary lesion of the heart. He was transferred to Ohio State University for further oncological management. There, he underwent surgery with resection. Biopsy results returned for angiosarcoma. He was started on Gemzar and Taxotere.
Discussion
Cardiac Sarcomas are rare malignant tumors of the heart. These primary cardiac malignant lesions have a dismal prognosis despite the enhanced diagnostic ability of newer technology. The reasons for the dismal prognosis are advanced tumor stage at presentation, unclear and non-specific symptomatology, lack of sufficient awareness due to the rarity and delayed/misdiagnosis which results in advanced tumor stage at presentation [6] .
Most frequent types of cardiac sarcomas include angiosarcomas, rhabdomyosarcoma, fibrosarcoma, undifferentiated sarcomas, leiomyosarcomas, liposarcomas and synovial sarcomas. Angiosarcoma is the most common type, usually arises in the right atrium [7, 8] and frequently presents with pulmonary and or distant metastases [9] . Undifferentiated sarcoma is another common type that predominantly affects the left atrium 7 , typically presenting with locally advanced tumour [9] .
Cardiac sarcomas are usually asymptomatic until an advanced stage. When symptomatic, they present atypically because of non-specificity. Clinical manifestations occur due to different mechanisms including obstruction to blood flow through the heart, valvular dysfunction, local invasion causing arrhythmia or pericardial effusion with/without tamponade, tumor embolism and systemic involvement [6, 10] . The patients can complain of dyspnea, chest pain and/or generalized fatigue. No distinct physical features can be discovered on examination. Usually an audible plop can be heard through the mitral valve due to tumor prolapse. Embolization on the left side can lead to cerebrovascular accident and peripheral organ infarction. Compression effects on the larynx may cause dysphonia and on the superior vena cava may cause superior venal cava syndrome.
Echocardiography, computed tomography and MRI are the most common diagnostic and staging modalities used to delineate tumor presence and extension. Echocardiogram is mostly the initial imaging modality for cardiac tumors with Trans-esophageal Echocardiogram providing more detailed information about tumor location and extent compared with Trans-thoracic Echocardiogram [11] [12] [13] 18] . CT scan provides detailed information about the morphology, location and extent of mass and is very useful for assessment of extra cardiac disease and metastasis [14, 11, 15] . Cardiac MRI provides precise information about the location and involvement of myocardial as well as mediastinal structures [16, 17, 19] . CT scan is useful for assessing extra cardiac extension while MRI is better for evaluation of myocardial and great vessels invasion. Tumor biopsy is the gold standard for tissue diagnosis after detection of cardiac tumor with imaging modalities. While the mentioned imaging techniques in isolation are helpful in making a diagnosis, using them is conjunction with each other was most helpful in making our diagnosis. As with the cases above, definitive diagnosis comes from surgical tissue or cytological biopsy.
Patient's survival strictly depends upon the stage of the disease and the possibility of complete surgical excision. Survival rates are better with complete resection of the tumor compared to incomplete resection and metastatic disease [20] . In a series of 34 cardiac sarcoma patients, median survival period of patients with metastatic disease was 5 months, compared with 15 months in patients without metastatic disease [21] . Some case reports have documented survival up to 25 months in patients with early disease [22] . High grade sarcomas have been associated with the worse prognosis [23] . Most of the patients ultimately die of metastasis or heart failure [24] .
Complete surgical resection has been reported to improve survival the most and whenever possible, is the treatment of choice [25, 26] . In a case series, patients who underwent surgery had a median survival of 12 months whereas those who did not undergo surgery had a median survival of 1 month [25] . Surgery also has a role in palliative resections for relief of symptoms and biopsy to confirm diagnosis [26] .
Although complete resection is the treatment of choice, it is not an option in many cases either because of the extensive local expansion of the tumor at the time of diagnosis or because of the presence of distant metastases [27] . Complete resection of the tumor in combination with adjuvant chemoradiotherapy offers the best chance at survival [28, 29, 30] . Despite promising responses to chemotherapy in some studies treatment approaches that involve neo-adjuvant chemotherapy and radiotherapy remain purely experimental [26] .
There is no general agreement on efficacy of postsurgical therapy for cardiac sarcomas. Chemotherapy after surgical resection is recommended, even when clear surgical margins are obtained because of the high probability of missed microscopic disease and likely aggressive course. [31] .
Although radiotherapy has been used for treatment of positive margins after resections, palliation of aggressive localized disease and local or isolated distant recurrence, its role remains unproven and only anecdotal responses are reported [25, 31, 32] .
In selected patients without extra cardiac disease, cardiac transplantation has been reported to improve survival, with most of these patients undergoing chemotherapy and radiation therapy prior to transplantation [33] [34] [35] [36] .
Cardiac auto-transplantation which consists of explantation of heart, complete tumor excision in vivo, reconstruction of heart and then re-implantation in native position has also been reported in few case reports to prolong survival [35, 36] .
